Dallas – October 01, 2026 -- Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has accepted and granted priority review to Nanoscope Therapeutics' New Drug Application for MOGENRY (sonpiretigene isteparvovec, MCO-010), an optogenetic gene therapy for inherited retinal dystrophies (IRDs). If approved by the Ministry of Health, Labour and Welfare, MOGENRY would become the first disease-agnostic treatment available to IRD patients in Japan, a condition caused by mutations across more than 250 genes that leads to progressive photoreceptor loss and blindness.

Courbevoie – October 01, 2026 -- ACI EUROPE, Amadeus, IATA, IDEMIA Public Security and SITA have formed the Responsible Biometrics Travel Industry Coalition, pressing EU policymakers to prevent the bloc's Digital Omnibus legislation from restricting voluntary biometric use in air travel.

The five organizations argue the current legislative proposal, designed to simplify Europe's digital rulebook and strengthen competitiveness, could unintentionally curb passengers' ability to opt into biometric verification at airports.

Los Angeles – September 30, 2026 -- Langar Investment Management, LLC will liquidate and close the Langar Global HealthTech ETF (Ticker: LGHT), a series of the Spinnaker ETF Series, after the Trust's Board of Trustees approved a Plan of Liquidation and Termination.

Chennai – – September 30, 2026 -- MPS Limited said its Artificial Intelligence Management System has been certified to ISO/IEC 42001:2023, the first international standard for AI management systems, following a multi-stage external audit by DNV Business Assurance.

Secaucus, N.J. – September 30, 2026 -- Pierre Fabre Pharmaceuticals Inc. (PFP) has resubmitted a Biologics License Application to the U.S. Food and Drug Administration for tabelecleucel, seeking approval as a monotherapy for adult and pediatric patients aged 2 and older with relapsed or refractory Epstein-Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD) who have failed at least one prior therapy.

Vancouver – – September 30, 2026 -- Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) has extended its shareholder proxy voting deadline to September 30, 2026 at 4:00 p.m. Pacific time, after approving a further revision to a special resolution governing amendments to the Company's corporate Articles ahead of its annual general and special meeting scheduled for October 2, 2026.

Indianapolis – September 30, 2026 -- Eli Lilly and Company (NYSE: LLY) said its EBGLYSS (lebrikizumab-lbkz) monotherapy met the primary and secondary endpoints of the Phase 3b ADtouch study at Week 16, with more than half of treated patients achieving clear or almost clear skin on hands and feet (HF-IGA 0/1), the company disclosed ahead of the European Academy of Dermatology and Venereology Congress in Vienna, running Sept. 30-Oct. 3.

Phnom Penh – September 29, 2026 -- Cambodia, Indonesia, the Philippines, and Thailand are shipping raw critical minerals abroad while processing and value capture happen elsewhere, according to a new report from Fair Finance Asia (FFA) and research partner Profundo.

The Bronx, N.Y. – September 29, 2026 -- The International Organization for Standardization published the third revision of ISO 3941 on January 21, 2026, introducing Class L as a distinct fire classification for lithium-ion cell and battery fires, arriving as New York City enforces a 1 kWh threshold for lithium-ion energy storage systems under its amended NFPA 855 code.

Kista, Sweden – September 29, 2026 -- Sivers Semiconductors AB has called an Extraordinary General Meeting for 22 October 2026 to replace auditor Deloitte AB with Ernst & Young AB, a move tied to the company's plan for a dual listing on U.S. capital markets expected in the first half of 2027.